title: Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab.
authors.forename: Michael
authors.initials: M
authors.lastname: Marnane
authors.forename: Timothy
authors.initials: T
authors.lastname: Lynch
authors.forename: Jaqueline
authors.initials: J
authors.lastname: Scott
authors.forename: John
authors.initials: J
authors.lastname: Stack
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Kelly
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D013256:Steroids / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002491:Central Nervous System Agents; D013256:Steroids; D000068879:Adalimumab